Phytosynthese and Bemipharm announce the availability of the production area of their new industrial site, Phytoplant 4.0, at the Biopôle Clermont-Limagne.
30 June 2025
Horée and Its Fresh Cosmetics Join the Amazon Sustainability Accelerator 2025.
3 June 2025
StrainChem and Euroapi enter into a collaboration for liquid-phase peptide synthesis.
5 May 2025
Alphanosos concludes a research partnership to explore plant-based solutions for neurodevelopmental disorders.
14 April 2025
Greencell leads NutriTious, a collaborative project for the formulation of new functional and sustainable foods for nutrition and gut microbiota.
25 March 2025
Carbogen AMCIS Obtains GMP certification for its sterile drug manufacturing site in Saint-Beauzire.
11 March 2025
Phytosynthèse is building its new production unit at the Biopôle Clermont-Limagne.
10 January 2025
Heading towards 2025: IPC invests in a 2500 m² building to support the development of its Clermont site.
9 December 2024
Oncosema and the STC Finder consortium awarded by the Lyon Auvergne-Rhône-Alpes Cancéropole.
10 October 2024
Horée Raises 330,000 Euros and continues Its Breakthrough in the Cosmetic Industry.
26 September 2024
Meet-up Pharma, a Day Dedicated to Health Industry Careers in Auvergne, will be Held on October 12th in Clermont-Ferrand.
24 September 2024
Greentech Acquires the Plant Extraction Activities of Laboratoire Gifrer.
23 September 2024
Verdot invests 10 million euros at the Biopôle Clermont-Limagne.
17 September 2024
Eric Portier, new président of the Biopôle Clermont-Limagne Unrestricted Public Sector Association.
5 April 2024
Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May.
30 November 2023
Alphanosos announces international partnership with Eurofragance.
22 September 2023
“Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups.
10 July 2023
ONCOSEMA EST LAURÉATE DU CONCOURS DE L’INNOVATION I-LAB.
4 July 2023
Sabi Agri launches ZILUS, its 100% electric oll-terrain robot.
23 May 2023
Valbiotis annonce le large succès de l’étude clinique de Phase II/III internationale multicentrique REVERSE-IT sur TOTUM•63 qui démontre son efficacité sur le principal facteur de risque du diabète de type 2.
17 April 2023
The Riom La Varenne pharmaceutical site is part of the SMO Biopôle Clermont-Limagne for now 10 years.
17 March 2023
The SMO Biopôle Clermont-Limagne publishes its panorama and key figures for 2022.
6 February 2023
Inauguration of the new Carbogen AMCIS production unit on the Biopôle Clermont-Limagne.
6 January 2023
SABI AGRI raises €8 million to become a leader in agroecological robotics.
15 December 2022
Intestinal microbiota: Valbiotis Research signes a research partnership with the MEDIS2 Unit from the Clermont Auvergne University.
13 December 2022
It is good to live and work at Biopôle Clermont-Limagne!
3 October 2022
“Accelerate your plant innovation!” VEGEPOLYS VALLEY is launching the 7th edition of its competition dedicated to start-ups.
22 September 2022
MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.
14 June 2022
Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.
9 June 2022
ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.
5 April 2022
Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?
1 April 2022
Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.
14 February 2022
Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.
21 December 2021
The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.
17 December 2021
STRAINCHEM enters the semi-industrial phase with France Relance.
29 November 2021
Carbios receives support from the European Commission through the LIFE program.
19 November 2021
Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.
11 October 2021
Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.
25 May 2021
Valbiotis obtains patent for its active substance TOTUM-63 in China.
27 April 2021
Carbios and Michelin on their way to 100% sustainable tires.
12 April 2021
With its extension project supported by France Relance, the Icare group strengthens its development ambitions.
15 January 2021
Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne
